White Papers

An Innovation Roadblock: The Shrinking Availability of Venture Capital in MedTech

Posted January 19, 2018| Prem Meyyan

The medical device sector, like many health segments, is driven by the usual suspects: a growing elderly population, rising prevalence of debilitating diseases, increased importance on quality-of-life, and innovation through painstaking research and development (R&D) efforts.

The latter, the only factor that industry players has any influence over, presents significant potential to cause a paradigm shift in how we approach the treatment and management
of diseases. By extension, innovation, whether in technological hardware or software or other key elements, could drive explosive growth across numerous product segments. What’s the challenge, then? In a word: funding.

Download the Whitepaper:

  • This field is for validation purposes and should be left unchanged.

Tags: , , , , ,

Related Resources

Read More

Competitive Intelligence (CI) Dictionary

Competitive Intelligence is the collection and analysis of information to anticipate competitive activity, see past market disruptions and dispassionately interpret […]

Read More

Early Warning Toolkit

Establish an early warning system that keeps your company one step ahead of market trends + competitors. Early warning programs empower […]

Read More

Planning for the Unpredictable, The Future of Healthcare: The Shifting Burden of Risk

Given the uncertainty surrounding the healthcare industry, stakeholders struggle to develop business strategies that can guide both near- and long-term […]

z

Subscribe to our mailing list for our latest updates: